SCHEMBL21832205

SCHEMBL21832205

CCS(=O)(=O)c1cc(O)cnc1-c1cn2cnc(C(F)(F)F)cc2n1

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.32
DDR1 Q08345 2/20 0.31
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
EGLN1 Q9GZT9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16346465 0.88 PTGS2 (0.34) KCNH2DDR1NPC1RAB9A
SCHEMBL17732142 0.88 DDR1 (0.33) KCNH2DDR1NPC1RAB9A
SCHEMBL17732195 0.88 DDR1 (0.35) KCNH2DDR1NPC1RAB9AEGLN1
SCHEMBL20233511 0.88 KCNH2 (0.36) KCNH2NPC1RAB9A
SCHEMBL21750098 0.87 EGLN1 (0.38) KCNH2DDR1EGLN1
SCHEMBL21761678 0.87 KCNH2 (0.31) KCNH2
SCHEMBL21750127 0.86 DDR1 (0.35) KCNH2DDR1EGLN1
SCHEMBL21750110 0.86 DDR1 (0.33) KCNH2DDR1EGLN1
SCHEMBL21832208 0.86
SCHEMBL21832210 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110612301-B Imidazopyrimidine derivatives having sulfur-containing phenyl and pyridyl substituents 先正达参股股份有限公司 2023-05-23 CN disclosed
EP-3621965-B1 IMIDAZOPYRIMIDINE DERIVATIVES WITH SULFUR CONTAINING PHENYL AND PYRIDYL SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2022-02-23 EP disclosed
US-10945435-B2 Imidazopyrimidine derivatives with sulfur containing phenyl and pyridyl substituents SYNGENTA PARTICIPATIONS AG (CH) 2021-03-16 US disclosed
US-10945435-B2 Imidazopyrimidine derivatives with sulfur containing phenyl and pyridyl substituents SYNGENTA PARTICIPATIONS AG (CH) 2021-03-16 US disclosed
US-20200100502-A1 IMIDAZOPYRIMIDINE DERIVATIVES WITH SULFUR CONTAINING PHENYL AND PYRIDYL SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2020-04-02 US disclosed
US-20200100502-A1 IMIDAZOPYRIMIDINE DERIVATIVES WITH SULFUR CONTAINING PHENYL AND PYRIDYL SUBSTITUENTS SYNGENTA PARTICIPATIONS AG (CH) 2020-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10945435-B2 Imidazopyrimidine derivatives with sulfur containing phenyl and pyridyl substituents PNPO, DDT, TH KCNH2 3019/4885DDR1 3397/4885NPC1 3836/4885
US-20200100502-A1 IMIDAZOPYRIMIDINE DERIVATIVES WITH SULFUR CONTAINING PHENYL AND PYRIDYL SUBSTITUENTS PNPO, DDT, TH KCNH2 3019/4885DDR1 3397/4885NPC1 3836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.